Across 46 countries and more than three million cases, a pattern has emerged that speaks to something older than the pandemic itself — the biological architecture of sex. Men and women encounter the coronavirus at equal rates, yet once inside the body, the virus follows different paths depending on the immune landscape it finds. Women carry molecular advantages, from interferon proteins to estradiol, that appear to soften the blow; men, whose immune response is tempered by testosterone, face nearly triple the risk of intensive care and a 39 percent higher chance of death. Science is now asking
Men with COVID-19 three times more likely to need intensive care, study finds
Men infected with COVID-19 face significantly higher risk of severe illness requiring intensive care and death compared to women.
Sex is an under reported variable in many studies
Mark
Why does it matter that men and women get infected at the same rate if the outcomes are so different?
Mimi
Because it tells us the problem isn't exposure or behavior—it's biology. If men were getting sick more often, we'd ask different questions. But they're not. They're just dying at higher rates once they're infected, which points directly to how their bodies handle the virus.
Mark
The study mentions testosterone suppresses immunity. Is that always a disadvantage, or does it serve some other purpose?
Mimi
Testosterone does other things for the body, but in the context of a viral infection, suppression of the immune response is purely a liability. There's no upside when you're fighting a pathogen.
Mark
If women have these natural advantages, why weren't they discovered earlier in the pandemic?
Mimi
They were being discovered in real time. This study synthesized three million cases to make the pattern unmistakable. Early on, hospitals were still scrambling to understand who was at highest risk. Now we have the data to say it clearly.
Mark
What happens with vaccines if men's immune systems respond differently?
Mimi
That's the open question. A vaccine might work brilliantly in women but less effectively in men, or vice versa. We won't know until we test it. The researchers are saying: don't assume the sexes will respond identically. Build that into the trial design from the start.
Mark
Does this change how doctors should treat male COVID patients differently?
Mimi
It should make them more cautious. If a male patient shows early signs of deterioration, the data suggests he's at higher risk of needing intensive care. That awareness could shift when doctors escalate treatment or move someone to the ICU.
O Pulso
- A global study of over three million COVID-19 cases has confirmed that men die from the virus at dramatically higher rates than women — not because they catch it more, but because their bodies fight it less effectively.
- The immune system's sex-based architecture is at the center of the crisis: women produce more interferon proteins that suppress dangerous cytokine storms, while testosterone actively blunts the male immune response.
- Clinicians are being urged to treat biological sex as a formal risk factor when triaging and managing COVID-19 patients, a variable that has been quietly underreported across much of the research landscape.
- Researchers warn that the same sex-based immune differences may cause men and women to respond differently to COVID-19 vaccines, potentially requiring separate calibration of doses and efficacy benchmarks.
Across 46 countries and more than three million cases, a pattern has emerged that speaks to something older than the pandemic itself — the biological architecture of sex. Men and women encounter the coronavirus at equal rates, yet once inside the body, the virus follows different paths depending on the immune landscape it finds. Women carry molecular advantages, from interferon proteins to estradiol, that appear to soften the blow; men, whose immune response is tempered by testosterone, face nearly triple the risk of intensive care and a 39 percent higher chance of death. Science is now asking whether this ancient difference between bodies must also reshape how we build and measure the medicines meant to protect them.
A study published in Nature Communications, drawing on more than three million confirmed COVID-19 cases across 46 countries, has laid bare a striking biological divide: men infected with the coronavirus are nearly three times more likely to require intensive care than women, and 39 percent more likely to die. The disparity is not one of exposure — infection rates between the sexes were essentially identical during the study period — but of what happens once the virus takes hold.
The explanation lies in the immune system's fundamental architecture. Women naturally produce higher levels of type I interferon proteins, which help prevent the runaway immune reaction known as a cytokine storm, widely believed to drive the most severe COVID-19 outcomes. The hormone estradiol further strengthens female immune defenses by boosting T cell activity and antibody production. Testosterone, by contrast, suppresses immune function, leaving men more vulnerable to the virus's worst effects.
Kate Webb of the University of Cape Town, a co-author of the study, urged clinicians to formally recognize sex as a risk factor when managing patients. She also noted a troubling gap in the research landscape: sex is still routinely underreported as a variable in medical studies, despite its clear influence on disease severity and survival.
The researchers acknowledged that their data lacked full detail on comorbidities, though the global prevalence of conditions like hypertension and diabetes appeared roughly equal between men and women — suggesting underlying illness alone cannot account for the male disadvantage. Looking ahead, Webb called for sex to be treated as a standard variable in vaccine trials, warning that men and women may mount meaningfully different immune responses to COVID-19 immunizations, with real consequences for how efficacy is measured and doses are designed.
A sweeping analysis of more than three million confirmed coronavirus cases across 46 countries and 44 American states has revealed a stark biological reality: men who contract COVID-19 face nearly triple the risk of requiring intensive care compared to women, and are 39 percent more likely to die from the infection. The finding, published in Nature Communications and announced by researchers on Wednesday, points to fundamental differences in how male and female immune systems respond to the virus.
The disparity is not a matter of exposure. When scientists examined the raw infection data from the period between January and June 2020, they found that men and women contracted the virus at essentially identical rates—exactly half of all confirmed cases involved male patients. Yet once infected, the trajectories diverged sharply. Men landed in intensive care units at rates that dwarfed those of women, and their mortality risk climbed accordingly. The pattern held across geographies and populations, with only scattered exceptions.
Biologists attribute this gap to the architecture of the immune system itself. Women naturally produce higher levels of type I interferon proteins, molecules that act as a brake on the runaway immune cascade known as a cytokine storm—a condition believed to drive the most severe forms of COVID-19. Additionally, the hormone estradiol, which circulates in female bodies, appears to fortify immune defenses by enhancing the activity of T cells, the white blood cells that hunt down and destroy infected tissue, while simultaneously ramping up antibody production. Testosterone, by contrast, actively suppresses immune function in men, leaving them more vulnerable once the virus takes hold.
Kate Webb, a researcher at the University of Cape Town and co-author of the study, emphasized the practical implications for clinical care. "These data may help doctors to recognise that sex is a risk factor for severe disease when managing patients," she told AFP. She also flagged a methodological blind spot in the broader research landscape: sex remains an underreported variable in many studies, despite its clear importance as a determinant of disease severity and outcome.
The researchers acknowledged gaps in their analysis. While they documented the stark differences in hospitalization and mortality rates, they lacked comprehensive data on how other medical conditions—comorbidities like hypertension and diabetes—might compound the risk differently in men versus women. Interestingly, the global prevalence of these conditions appeared roughly equal between the sexes, suggesting that underlying health problems alone cannot explain the male disadvantage.
The findings carry weight beyond the immediate crisis. Vaccine development may reveal similar sex-based patterns. Previous immunizations against other infections have shown measurable differences in how male and female bodies respond, and Webb cautioned that the same may prove true for COVID-19 vaccines. She called for sex to be treated as a standard variable in vaccine research, not an afterthought. As the world races to deploy vaccines, understanding whether men and women will mount different immune responses—and at what strength—could reshape how doses are calibrated and how efficacy is measured across populations.
Citações Notáveis
Sex is an under reported variable in many studies and this is a reminder that it is an important factor to consider in research.— Kate Webb, University of Cape Town researcher
These data may help doctors to recognise that sex is a risk factor for severe disease when managing patients.— Kate Webb
Quer a matéria completa?
Leia o original em News18 ↗
Health & Medicine